These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9284196)

  • 21. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
    Stock RG; Stone NN; Ianuzzi C; Unger P
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):815-21. PubMed ID: 7591888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer.
    Briganti A; Chun FK; Salonia A; Gallina A; Farina E; Da Pozzo LF; Rigatti P; Montorsi F; Karakiewicz PI
    BJU Int; 2006 Oct; 98(4):788-93. PubMed ID: 16796698
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of laparoscopic pelvic lymphadenectomy in patients at high risk for nodal metastases from prostate cancer.
    Kava BR; Dalbagni G; Conlon KC; Russo P
    Ann Surg Oncol; 1998 Mar; 5(2):173-80. PubMed ID: 9527271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of lymphatic spreading in prostatic cancer by prostate-specific antigen and Gleason's score.
    Wu TT; Chen KK; Huang JK; Lee YH; Chen MT; Chang LS
    Eur Urol; 1994; 26(3):202-6. PubMed ID: 7528661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of preoperative plasma endoglin for prediction of lymph node metastasis in patients with clinically localized prostate cancer.
    Karam JA; Svatek RS; Karakiewicz PI; Gallina A; Roehrborn CG; Slawin KM; Shariat SF
    Clin Cancer Res; 2008 Mar; 14(5):1418-22. PubMed ID: 18316564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indications for pelvic lymphadenectomy in prostate cancer.
    Link RE; Morton RA
    Urol Clin North Am; 2001 Aug; 28(3):491-8. PubMed ID: 11590808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eliminating the need for bilateral pelvic lymphadenectomy in select patients with prostate cancer.
    Bluestein DL; Bostwick DG; Bergstralh EJ; Oesterling JE
    J Urol; 1994 May; 151(5):1315-20. PubMed ID: 7512662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen and Gleason score to predict prostate cancer stage.
    Poulakis V; Witzsch U; De Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
    J Urol; 2004 Oct; 172(4 Pt 1):1306-10. PubMed ID: 15371829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is pelvic lymph node dissection necessary in patients with a serum PSA<10ng/ml undergoing radical prostatectomy for prostate cancer?
    Schumacher MC; Burkhard FC; Thalmann GN; Fleischmann A; Studer UE
    Eur Urol; 2006 Aug; 50(2):272-9. PubMed ID: 16632187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indications for laparoscopic pelvic lymph node dissection in the staging of prostate cancer.
    Patel MI; Katelaris PM
    Aust N Z J Surg; 1995 Apr; 65(4):233-6. PubMed ID: 7536410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Value of PSA and (pre- postoperative) Gleason in predicting the potential lymphatic involvement in patients with prostatic cancer].
    Gómez Veiga F; Díaz Bermúdez J; Alvarez Castelo L; Lorenzo Patiño MJ; Rodríguez Rivera J; Chantada Abal V; Vázquez Martul E; González Martín M
    Arch Esp Urol; 1997; 50(1):33-9. PubMed ID: 9182486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of pretherapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens.
    Pisansky TM; Zincke H; Suman VJ; Bostwick DG; Earle JD; Oesterling JE
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):33-9. PubMed ID: 12118563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the complexed-to-total prostate-specific antigen ratio in predicting the final pathological stage of clinically localized prostate cancer.
    Martínez M; Navarro S; Medina P; Villavicencio H; Rioja L; Solsona E; Estellés A; Aznar J; Jiménez-Cruz JF; España F
    Eur Urol; 2003 Jun; 43(6):609-14. PubMed ID: 12767360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pelvic lymph node dissection in prostate cancer.
    Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
    Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laparoscopic pelvic lymph node dissection in the staging of prostate cancer.
    Stone NN; Stock RG
    Mt Sinai J Med; 1999 Jan; 66(1):26-30. PubMed ID: 9989102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer.
    Spencer JA; Chng WJ; Hudson E; Boon AP; Whelan P
    Br J Radiol; 1998 Nov; 71(851):1130-5. PubMed ID: 10434906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laparoscopic extended pelvic lymph node dissection for high-risk prostate cancer.
    Wyler SF; Sulser T; Seifert HH; Ruszat R; Forster TH; Gasser TC; Bachmann A
    Urology; 2006 Oct; 68(4):883-7. PubMed ID: 17070376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
    Horiguchi A; Nakashima J; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
    Prostate; 2003 Jun; 56(1):23-9. PubMed ID: 12746843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Staging laparoscopic pelvic lymphadenectomy in prostate cancer.
    Shackley DC; Irving SO; Brough WA; O'Reilly PH
    BJU Int; 1999 Feb; 83(3):260-4. PubMed ID: 10233490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.